| Literature DB >> 26689472 |
Sumitra Miriyala1, Chadinee Thippakorn2, Luksana Chaiswing3, Yong Xu4, Teresa Noel4, Artak Tovmasyan5, Ines Batinic-Haberle5, Craig W Vander Kooi6, Wang Chi7, Ahmed Abdel Latif8, Manikandan Panchatcharam9, Virapong Prachayasittikul2, D Allan Butterfield10, Mary Vore4, Jeffrey Moscow11, Daret K St Clair12.
Abstract
Cardiovascular complications are major side effects of many anticancer drugs. Accumulated evidence indicates that oxidative stress in mitochondria plays an important role in cardiac injury, but how mitochondrial redox mechanisms are involved in cardiac dysfunction remains unclear. Here, we demonstrate that 4-hydroxy-2-nonenal (HNE) activates the translocation of the mitochondrial apoptosis inducing factor (AIFm2) and facilitates apoptosis in heart tissue of mice and humans. Doxorubicin treatments significantly enhance cardiac levels of HNE and AIFm2. HNE adduction of AIFm2 inactivates the NADH oxidoreductase activity of AIFm2 and facilitates its translocation from mitochondria. His 174 on AIFm2 is the critical target of HNE adduction that triggers this functional switch. HNE adduction and translocation of AIFm2 from mitochondria upon Doxorubicin treatment are attenuated by superoxide dismutase mimetics. These results identify a previously unrecognized role of HNE with important consequences for mitochondrial stress signaling, heart failure, and the side effects of cancer therapy.Entities:
Keywords: AIFm2; HNE adduction; Mitochondria; Superoxide dismutase mimetics
Mesh:
Substances:
Year: 2015 PMID: 26689472 PMCID: PMC4761499 DOI: 10.1016/j.freeradbiomed.2015.12.002
Source DB: PubMed Journal: Free Radic Biol Med ISSN: 0891-5849 Impact factor: 7.376